Comprehensive Ophthalmologist Program Overview

CME INFORMATION

COMPREHENSIVE PROGRAM

Evaluations and CME Certificates

Online evaluations will be available on the first day of the meeting. Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience

The intended audience for this activity is comprehensive ophthalmologists.

Program Summary

Join your colleagues for a unique educational experience. You will be offered opportunities to engage faculty and peers in both large and small group settings, appealing to all learning styles and comfort levels. Over 100 presenters consisting of ophthalmology’s brightest minds will help take your skills to the next level and explain how to incorporate cutting-edge procedures and technologies into your practice. In addition to today’s hot topics, you’ll receive a comprehensive update on every aspect of your practice. Plus, extend your learning beyond the meeting room by attending nightly banyan tree sessions featuring open discussions in a relaxed, outdoor setting. Comprehensive Ophthalmologist Program attendees are also able to attend sessions of interest under the Retina Program. This program offers an unopposed schedule including: Breakfast programs, general sessions, exhibit hall breaks, lunch programs, afternoon programs, banyan tree sessions and evening programs (all included in the single registration fee).

Learning Objectives: General Sessions

Upon completion of this activity, attendees will have better knowledge of the following subject matters:

Saturday Morning CME General Sessions:

Describe the latest advances in surgical repair of eyelid lesions and malpositions, as well as the management of periocular trauma, brow ptosis, and thyroid eye disease.
Evaluate procedures for upper and lower eyelid blepharoplasty, the use of neuromodulators and fillers, as well as novel injection strategies that can minimize complications.
Assess the role of non-surgical aesthetic enhancements in everyday clinical practice.
Evaluate current evidence on toxins, fillers, and topical products used in aesthetic procedures.

Saturday Afternoon – Friday CME General Sessions:

Examine functional and aesthetic oculoplastic skills that will strengthen the ability to identify and treat common eyelid lesions, malpositions, ptosis, thyroid eye disease, and periocular trauma, as well as illustrate the ability to incorporate non-surgical aesthetic enhancements into an ophthalmology practice.
Assess instrumentation for cataract removal, current options and indications for intraocular lenses, and perioperative procedures that may achieve better results in patients.
Describe the current status of lens selection and replacement surgery using multifocal, trifocal, toric, accommodating intraocular lens implants, extended depth of focus IOLs, and refractive IOLs, as well as their impact on patient results.
Identify new techniques and develop strategies for the management of cataract, cataract with glaucoma, and refractive surgery complications.
Recognize new treatment techniques and technologies, and the benefit of preoperative decision making, to improve patient satisfaction following cataract and/or refractive surgery.
Examine the use of medical, surgical, and new management tools that have the potential to improve outcomes in patients with glaucoma.
Analyze current concepts for the management of corneal and external diseases, ocular surface disorders, ocular infection, inflammation, and pain.
Recognize, evaluate, and manage neuro-ophthalmologic processes.
Examine the latest updates in practice management that serve to improve patient care.
Summarize the latest evidence pertaining to the medical management of retinal disorders and uveitis.
Assess the changing ophthalmic practice environment and how ophthalmologists can improve patient care amid the COVID-19 era.

This continuing medical education activity is provided by

Hawaiian Eye 2021 is supported by educational grants from Alcon Vision, LLC; AbbVie Inc.; Aerie Pharmaceuticals, Inc.; Allergan, Inc.; Bausch + Lomb; Dompé US, Inc.; Galderma Laboratories, L.P.; Genentech, Inc., a member of the Roche Group; Horizon Therapeutics USA, Inc.; Kala Pharmaceuticals, Inc.; Oyster Point Pharma , Inc.; Regeneron Pharmaceuticals, Inc.; and Sun Pharmaceutical Industries, Inc.

Hawaiian Eye 2021 in-kind support is provided by Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; and Revance Therapeutics, Inc.

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 32.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.